You cannot register for this webinar
This webinar has ended. Thank you for your interest.
Topic
Capricor Therapeutics: Update on Deramiocel (CAP-1002) for the Treatment of Cardiomyopathy in Patients with Duchenne Muscular Dystrophy
Date & Time
Selected Sessions:
Mar 6, 2025 01:00 PM
Description
Please join PPMD and Capricor Therapeutics for a community webinar on Thursday, March 6, 2025 at 1:00PM ET. The Capricor team will provide a current update on the company’s Biologics License Application (BLA) seeking full approval of deramiocel (CAP-1002), Capricor’s novel cell therapy for the treatment of cardiomyopathy in patients diagnosed with Duchenne. Please submit questions in advance: https://forms.gle/8FG5YUZZ4nBTiP7L9